PCSK9 Inhibitor Development Stoppage Highlights Week in Specialty Pharmacy

Nov 4, 2016

Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/pcsk9-inhibitor-development-stoppage-highlights-we" target="_blank">View the story "PCSK9 Inhibitor Development Stoppage Highlights Week in Specialty Pharmacy" on Storify</a>]

Related Videos

Biosimilars | Image credit: lexiconimages - stock.adobe.com

Medical care team | Image credit: Iryna - stock.adobe.com

Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com

Medical science laboratory | Image credit: alphaspirit - stock.adobe.com

Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com

Pharmacist managing inventory | Image credit: StratfordProductions - stock.adobe.com

Nursing giving infusion to senior patient | Image credit: Studio Romantic - stock.adobe.com

Cirrhosis illustration | Image credit: Rasi - stock.adobe.com

Related Content

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Medication Acquisition Programs Can Improve Access to Treatment

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Related Content

Pharmacist holding medicine box and capsule pack in pharmacy drugstore. Credit: I Viewfinder - stock.adobe.com

Key Metrics That Support the Integrated Specialty Pharmacy Model

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

Image Credit: Adobe Stock - motortion

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Credit: Prostock-studio - stock.adobe.com.

Medication Acquisition Programs Can Improve Access to Treatment

Credit: TarikVision - stock.adobe.com

Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.